AKT1 and cancer: Furthermore, Mammalian target of rapamycin (mTOR), a serine/threonine kinase which is a key player in the PI3K/Akt pathway, acting both up and downstream of Akt [22–25] has also been linked with a variety of cancers when dysregulated.